N-[(4R)-4-benzyl-5-[[(5S)-6-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-5-methyl-2,6-dioxohexyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide

C56H61FN6O12 — CID 159499216

IUPACN-[(4R)-4-benzyl-5-[[(5S)-6-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-5-methyl-2,6-dioxohexyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide
SMILESCC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](NC(=O)[C@@H](C)CCC(=O)CNC(=O)C(CC(=O)CNC(=O)CCC(=O)CCCCCN1C(=O)C=CC1=O)Cc1ccccc1)CC3
InChIInChI=1S/C56H61FN6O12/c1-4-56(74)41-25-45-51-39(29-63(45)54(72)40(41)30-75-55(56)73)50-43(18-17-38-32(3)42(57)26-44(60-51)49(38)50)61-52(70)31(2)14-15-36(65)27-59-53(71)34(23-33-11-7-5-8-12-33)24-37(66)28-58-46(67)19-16-35(64)13-9-6-10-22-62-47(68)20-21-48(62)69/h5,7-8,11-12,20-21,25-26,31,34,43,74H,4,6,9-10,13-19,22-24,27-30H2,1-3H3,(H,58,67)(H,59,71)(H,61,70)/t31-,34?,43-,56-/m0/s1
InChIKeyNWVYRPLIZLODMY-PCDAYPLVSA-N
MW1029.13 g/mol
LogP4.50
Rot. Bonds24

About N-[(4R)-4-benzyl-5-[[(5S)-6-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-5-methyl-2,6-dioxohexyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide

N-[(4R)-4-benzyl-5-[[(5S)-6-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-5-methyl-2,6-dioxohexyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide (PubChem CID 159499216) has the molecular formula C56H61FN6O12 and a molecular weight of 1029.13 g/mol. Its IUPAC name is N-[(4R)-4-benzyl-5-[[(5S)-6-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-5-methyl-2,6-dioxohexyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide.

Molecular Properties

Compound NameN-[(4R)-4-benzyl-5-[[(5S)-6-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-5-methyl-2,6-dioxohexyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide
PubChem CID159499216
Molecular FormulaC56H61FN6O12
Molecular Weight1029.13 g/mol
Exact Mass1028.43
IUPAC NameN-[(4R)-4-benzyl-5-[[(5S)-6-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-5-methyl-2,6-dioxohexyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide
SMILESCC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](NC(=O)[C@@H](C)CCC(=O)CNC(=O)C(CC(=O)CNC(=O)CCC(=O)CCCCCN1C(=O)C=CC1=O)Cc1ccccc1)CC3
InChIInChI=1S/C56H61FN6O12/c1-4-56(74)41-25-45-51-39(29-63(45)54(72)40(41)30-75-55(56)73)50-43(18-17-38-32(3)42(57)26-44(60-51)49(38)50)61-52(70)31(2)14-15-36(65)27-59-53(71)34(23-33-11-7-5-8-12-33)24-37(66)28-58-46(67)19-16-35(64)13-9-6-10-22-62-47(68)20-21-48(62)69/h5,7-8,11-12,20-21,25-26,31,34,43,74H,4,6,9-10,13-19,22-24,27-30H2,1-3H3,(H,58,67)(H,59,71)(H,61,70)/t31-,34?,43-,56-/m0/s1
InChIKeyNWVYRPLIZLODMY-PCDAYPLVSA-N
XLogP4.50
TPSA257.31 Ų
H-Bond Donors4
H-Bond Acceptors14
Rotatable Bonds24
Heavy Atoms75
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001029.13
LogP ≤ 54.50
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze N-[(4R)-4-benzyl-5-[[(5S)-6-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-5-methyl-2,6-dioxohexyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(4R)-4-benzyl-5-[[(5S)-6-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-5-methyl-2,6-dioxohexyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide?
The IUPAC name of N-[(4R)-4-benzyl-5-[[(5S)-6-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-5-methyl-2,6-dioxohexyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide (CID 159499216) is N-[(4R)-4-benzyl-5-[[(5S)-6-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-5-methyl-2,6-dioxohexyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide.
What is the SMILES notation for N-[(4R)-4-benzyl-5-[[(5S)-6-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-5-methyl-2,6-dioxohexyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide?
The canonical SMILES for N-[(4R)-4-benzyl-5-[[(5S)-6-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-5-methyl-2,6-dioxohexyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide is CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](NC(=O)[C@@H](C)CCC(=O)CNC(=O)C(CC(=O)CNC(=O)CCC(=O)CCCCCN1C(=O)C=CC1=O)Cc1ccccc1)CC3.
What is the InChIKey of N-[(4R)-4-benzyl-5-[[(5S)-6-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-5-methyl-2,6-dioxohexyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide?
The InChIKey is NWVYRPLIZLODMY-PCDAYPLVSA-N. The full InChI is InChI=1S/C56H61FN6O12/c1-4-56(74)41-25-45-51-39(29-63(45)54(72)40(41)30-75-55(56)73)50-43(18-17-38-32(3)42(57)26-44(60-51)49(38)50)61-52(70)31(2)14-15-36(65)27-59-53(71)34(23-33-11-7-5-8-12-33)24-37(66)28-58-46(67)19-16-35(64)13-9-6-10-22-62-47(68)20-21-48(62)69/h5,7-8,11-12,20-21,25-26,31,34,43,74H,4,6,9-10,13-19,22-24,27-30H2,1-3H3,(H,58,67)(H,59,71)(H,61,70)/t31-,34?,43-,56-/m0/s1.
What are the key properties of N-[(4R)-4-benzyl-5-[[(5S)-6-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-5-methyl-2,6-dioxohexyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide?
N-[(4R)-4-benzyl-5-[[(5S)-6-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-5-methyl-2,6-dioxohexyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide has a molecular weight of 1029.13 g/mol, XLogP of 4.50, 24 rotatable bonds, 4 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4R)-4-benzyl-5-[[(5S)-6-[[(10S,23S)-10-ethyl-18-fluoro-10-hydroxy-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-23-yl]amino]-5-methyl-2,6-dioxohexyl]amino]-2,5-dioxopentyl]-9-(2,5-dioxopyrrol-1-yl)-4-oxononanamide is sourced from PubChem (CID 159499216), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).